These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20869151)

  • 21. Bisphosphonates and osteonecrosis of the jaw: a retrospective study.
    Murad OM; Arora S; Farag AF; Guber HA
    Endocr Pract; 2007; 13(3):232-8. PubMed ID: 17599853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteonecrosis of the Jaw in Patients Receiving Bone-Targeted Therapies: An Overview--Part I.
    Turner B; Drudge-Coates L; Ali S; Pati J; Nargund V; Ali E; Cheng L; Wells P
    Urol Nurs; 2016; 36(3):111-6, 154. PubMed ID: 27501591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and treatment outcome.
    Yarom N; Yahalom R; Shoshani Y; Hamed W; Regev E; Elad S
    Osteoporos Int; 2007 Oct; 18(10):1363-70. PubMed ID: 17598065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persisting alveolar sockets-a radiologic symptom of BP-ONJ?
    Groetz KA; Al-Nawas B
    J Oral Maxillofac Surg; 2006 Oct; 64(10):1571-2. PubMed ID: 16982320
    [No Abstract]   [Full Text] [Related]  

  • 25. Osteonecrosis of the jaw associated with bisphosphonate therapy.
    Wirth SM; Lawson AP; Sutphin SD; Adams VR
    Orthopedics; 2009 Dec; 32(12):900. PubMed ID: 20000241
    [No Abstract]   [Full Text] [Related]  

  • 26. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw.
    Vahtsevanos K; Kyrgidis A; Verrou E; Katodritou E; Triaridis S; Andreadis CG; Boukovinas I; Koloutsos GE; Teleioudis Z; Kitikidou K; Paraskevopoulos P; Zervas K; Antoniades K
    J Clin Oncol; 2009 Nov; 27(32):5356-62. PubMed ID: 19805682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of osteonecrosis of the jaw in cancer patients taking bisphosphonates.
    Gebara SN; Moubayed H
    Am J Health Syst Pharm; 2009 Sep; 66(17):1541-7. PubMed ID: 19710437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation?
    Lesclous P; Abi Najm S; Carrel JP; Baroukh B; Lombardi T; Willi JP; Rizzoli R; Saffar JL; Samson J
    Bone; 2009 Nov; 45(5):843-52. PubMed ID: 19631301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
    O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
    J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonate-associated osteonecrosis of the jaw.
    Khan A
    Can Fam Physician; 2008 Jul; 54(7):1019-21. PubMed ID: 18625828
    [No Abstract]   [Full Text] [Related]  

  • 31. Osteonecrosis of the jaw in patients receiving intravenous or oral bisphosphonates.
    King AE; Umland EM
    Pharmacotherapy; 2008 May; 28(5):667-77. PubMed ID: 18447663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
    Perrotta I; Cristofaro MG; Amantea M; Russo E; De Fazio S; Zuccalà V; Conforti F; Amorosi A; Donato G; Tripepi S; Giudice M
    Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Osteonecrosis of the jaw in patients with multiple myeloma treated with zoledronic acid.
    Cetiner S; Sucak GT; Kahraman SA; Aki SZ; Kocakahyaoglu B; Gultekin SE; Cetiner M; Haznedar R
    J Bone Miner Metab; 2009; 27(4):435-43. PubMed ID: 19240969
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Introduction to osteonecrosis of the femoral head (OFH) and osteonecrosis of the jaw (ONJ).
    Kim HK
    J Musculoskelet Neuronal Interact; 2007; 7(4):350-3. PubMed ID: 18094509
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiresorptive drug-related osteonecrosis of the jaw.
    Uyanne J; Calhoun CC; Le AD
    Dent Clin North Am; 2014 Apr; 58(2):369-84. PubMed ID: 24655528
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteonecrosis of the jaw (ONJ) nomenclature--missing the forest for the trees?
    Subramanian G; Quek SY
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):666-7; author reply 667. PubMed ID: 23022024
    [No Abstract]   [Full Text] [Related]  

  • 37. Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: a retrospective analysis.
    Ortega C; Montemurro F; Faggiuolo R; Vormola R; Nanni D; Goia F; Gilardino MO; Aglietta M
    Acta Oncol; 2007; 46(5):664-8. PubMed ID: 17562443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy.
    Favia G; Pilolli GP; Maiorano E
    Bone; 2009 Sep; 45(3):406-13. PubMed ID: 19450715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program.
    Grbic JT; Black DM; Lyles KW; Reid DM; Orwoll E; McClung M; Bucci-Rechtweg C; Su G
    J Am Dent Assoc; 2010 Nov; 141(11):1365-70. PubMed ID: 21037195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbial biofilms in osteomyelitis of the jaw and osteonecrosis of the jaw secondary to bisphosphonate therapy.
    Sedghizadeh PP; Kumar SK; Gorur A; Schaudinn C; Shuler CF; Costerton JW
    J Am Dent Assoc; 2009 Oct; 140(10):1259-65. PubMed ID: 19797556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.